![Oliver Baumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver R.
Baumann is Chief Executive Officer & Director at Xlife Sciences AG since 2020, Chief Executive Officer at Akira Trading GmbH, Chairman at Akira Holding AG, Chairman & General Manager at Veraxa Biotech Holding AG, Director at Pecunia Solutions AG, Director at VERAXA Biotech AG, Director at Axenoll Life Sciences AG, and Co-Managing Director at Xrna.
Biotech GmbH.
Former roles include Chief Executive Officer at Belvoir Wealth Management AG and Co-Managing Director at x-diagnostics GmbH.
| Bedrijven | Functie | Begin |
|---|---|---|
| XLIFE SCIENCES AG | Algemeen Directeur | 01-07-2019 |
Pecunia Solutions AG | Directeur/Bestuurslid | - |
Axenoll Life Sciences AG | Directeur/Bestuurslid | - |
Akira Holding AG | Voorzitter | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Veraxa Biotech AG
 Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Directeur/Bestuurslid | - |
Belvoir Wealth Management AG
 Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 6 |
|---|---|
Belvoir Wealth Management AG
Belvoir Wealth Management AG Investment ManagersFinance Provides investment advice | Finance |
Pecunia Solutions AG | |
Xlife Sciences AG
 Xlife Sciences AG Miscellaneous Commercial ServicesCommercial Services Develops life sciences technologies | Commercial Services |
Akira Holding AG | |
Veraxa Biotech AG
Veraxa Biotech AG BiotechnologyHealth Technology Develops antibodies based therapeutics | Health Technology |
Axenoll Life Sciences AG |
Kies jouw editie
Alle financiële informatie op nationaal niveau
